HSBC Holdings
CLVS

HSBC Holdings’s Clovis Oncology, Inc. CLVS Stock Holding History

HSBC Holdings’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-51,942
Closed -$132K – 3530
2022
Q1 		$132K Buy
+51,942
New +$102K ﹤0.01% 3083
2020
Q3 		– Sell
-10,216
Closed -$69K – 2919
2020
Q2 		$69K Buy
+10,216
New +$77.4K ﹤0.01% 2558
2019
Q4 		– Sell
-42,882
Closed -$169K – 3244
2019
Q3 		$169K Buy
+42,882
New +$347K ﹤0.01% 2907
2018
Q4 		– Sell
-32,963
Closed -$968K – 2763
2018
Q3 		$968K Buy
+32,963
New +$1.28M ﹤0.01% 1762
2017
Q1 		– Sell
-5,475
Closed -$243K – 2682
2016
Q4 		$243K Buy
+5,475
New +$193K ﹤0.01% 2395

Other funds holding CLVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

HSBC Holdings's CLVS Position: Q2 2022 in Review

HSBC Holdings sold out of Clovis Oncology, Inc. (CLVS) in Q2 2022, closing a stake of 51,942 shares — an estimated $132K sold.

HSBC Holdings first reported a position in CLVS in Q4 2016 and held it in 5 quarters. The position peaked at $968K in Q3 2018. 115 funds tracked by Wall St. Rank hold CLVS as of Q2 2022.

  • HSBC Holdings reported no remaining Clovis Oncology, Inc. position as of Q2 2022 after selling out during the quarter.
  • HSBC Holdings sold 51,942 Clovis Oncology, Inc. shares in Q2 2022, an estimated $132K.
  • HSBC Holdings first reported a position in Clovis Oncology, Inc. in Q4 2016 and held it in 5 quarters.
  • HSBC Holdings's Clovis Oncology, Inc. position peaked at $968K in Q3 2018.
  • 115 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2022.

Based on HSBC Holdings's 13F filing for Q2 2022, filed 11 Aug 2022.